Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT 327 in mild to moderate psoriasis vulgaris
NCT00995969Phase 2Completed
- Sponsor
- Creabilis SA
- Start
- Mar 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pegcantratinib in Psoriasis vulgaris (PV), sponsored by Creabilis SA. Started Mar 2010; status: completed.
02
Drugs
pegcantratinib
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00995969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995969.